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Abstract
Stroke is a leading cause of disability and death worldwide. According to Slawski et al.
(2018), strokes will more than double in 2050, with the greatest percentage of affected
patients being over the age of 75. Administering interventions to patients affected by
acute ischemic stroke (AIS) has been a controversial topic when elderly patients were
involved (Alawieh et al., 2018). Elderly patients have been known to be excluded from
clinical trials solely due to their age and comorbidities (Karhi et al., 2018). The purpose
of this project was to determine if the use of endovascular thrombectomy (EVT) is
recommended for elderly patients over the age of 75 years of age who have suffered an
acute ischemic stroke from a large vessel occlusion (LVO). Six studies met inclusion and
were included in this systematic review. The overall findings of this systematic review
suggest the use of EVT to be effective for elderly patients over the age of 75 years of age
who have suffered an AIS from an LVO. Despite high mortality rates and less favorable
outcomes in the elderly cohorts in the six studies, four of the six articles concluded that
the alternative of not providing thrombectomy could have detrimental outcomes.
Implications of this systematic review include the importance of the advanced practice
nurse’s (APRN) role in advocating and educating patients and families about the benefits
of receiving thrombectomy after suffering an AIS from an LVO. In addition, APRNs
should educate their colleagues about the evidence regarding thrombectomy in order help
bridge the gap in the lack of knowledge regarding EVT in the elderly population.
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ENDOVASCULAR THROMBECTOMY FOR PATIENTS OVER THE AGE OF 75
WITH ACUTE ISCHEMIC STROKE:
A SYSTEMATIC REVIEW
Background/Statement of the Problem
Stroke is a leading cause of disability and death worldwide. According to Slawski
et al. (2018), approximately 30% of strokes affect patients over the age of 80, with 17%
of those patients being over the age of 85. The authors state that by 2050, strokes will
more than double, with the greatest percentage of affected patients being over the age of
75. With the progression of technology, there are many interventions that have, in many
opinions, either mitigated the detrimental effects of strokes or contributed to its
associated mortality rate. Administering interventions to patients affected by acute
ischemic stroke (AIS) has been a controversial topic when elderly patients were involved
(Alawieh et al., 2018). Elderly patients have been known to be excluded from clinical
trials solely due to their age and comorbidities (Karhi et al., 2018).
An ischemic stroke occurs when there is a clot in a blood vessel in the brain
depriving oxygen to that area. Intravenously administered tissue plasminogen activator
(tPA), also known as alteplase, is one of the most widely known interventions for AIS.
This medication is a protein that lyses or breaks down blood clots to allow reperfusion to
the area of the brain where the blood vessel was once occluded. Endovascular
thrombectomy (EVT) has proven efficacy and safety and is considered the gold standard
for treating AIS patients with large vessel occlusions (LVO) regardless of whether tPA
was administered prior to EVT (Meyer et al., 2020). Evaluation for tPA administration
and EVT happens simultaneously (Powers et al., 2019). Tissue plasminogen activator can
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be administered prior to EVT if no contraindications to tPA exist; contraindications will
be discussed below in the ‘standard treatment for AIS’ section.
It is crucial to determine whether lifesaving treatments prolong elderly patients’
quality and/or quantity of life. Family members and or patients should carefully consider
the side effects of these potentially lifesaving treatments. Preexisting conditions and
baseline functionality should be taken into consideration as these are pertinent factors in
the decision to accept or decline treatment. Co-morbid conditions greatly impact quality
of life and should considered when determining appropriate treatment options for each
patient. Stroke severity and treatment timeframe affect a patient’s outcome and quality of
life. It is crucial to bridge the gap in the lack of knowledge regarding outcomes of AIS
treatments in the elderly population. Malhotra et al. (2019) discuss concerns raised about
the use of thrombectomy in elderly patients related to poor functional outcomes. On the
other hand, the American Stroke Association’s (ASA) 2019 updated guidelines did not
include an age cut off for EVT. The patient does, however, have to be over the age of 18,
(Powers et al., 2019). Nonetheless, the guidelines advise the careful consideration of
patient comorbidities when considering treatment options.
The purpose of this project was to determine if the use of endovascular
thrombectomy is recommended for elderly patients over the age of 75 years of age who
have suffered an acute ischemic stroke from a large vessel occlusion.
Next, a review of the literature will be presented.
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Literature Review
An extensive search in the Cumulative Index of Nursing and Allied Health
Literature (CINAHL) Plus with Full Text, PubMed, and Google Scholar databases was
conducted to find articles published about endovascular thrombectomy in elderly patients
who have suffered AIS with an LVO. Keywords searched included: endovascular
thrombectomy, ischemic stroke, hemorrhagic stroke, transient ischemic stroke, tPA,
stroke and age-related complications, stroke and co-morbidities, efficacy of endovascular
thrombectomy, endovascular treatment, and benefits to thrombectomy for elderly
patients. Articles written between 2010 and 2021 were reviewed to determine the efficacy
of endovascular thrombectomy for patients who have suffered an acute ischemic stroke
involving a large vessel occlusion. The administration of tPA was not a contraindication
to EVT in the articles, nor was tPA an exclusion to the studies.
Stroke Pathophysiology
An ischemic stroke occurs when a clot compromises perfusion of the brain and
deprives it of oxygen and nutrients and is the most common type of stroke, accounting for
83% of all strokes. Hemorrhagic stroke accounts for 17% of all strokes and is outside the
scope of this review. Transient ischemic attack (TIA) is considered a ‘mini stroke’ and a
warning sign of an impending stroke. TIAs occur in two percent of adults in the United
States and are also outside the scope of this review (Barkley, 2021).
There are modifiable and nonmodifiable risk factors for ischemic stroke.
Modifiable risk factors include hypertension, diabetes, atrial fibrillation,
hypercholesteremia, hyper-coagulopathy, smoking, alcohol use, sedentary lifestyle, oral
contraceptives, hormone replacement therapy, and illicit drug use. Nonmodifiable risk
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factors include heart disease, prior stroke, advanced age, male gender, older female,
race/ethnicity, family history of stroke, polycythemia, and sickle cell disease (Kuriakose
et al., 2020). The treatment of modifiable risk factors and cessation of activities that
induce a stroke can greatly reduce one’s chance of developing a stroke.
Ischemic Stroke
The flow of blood to the brain is controlled by two internal carotid arteries and
two vertebral arteries. A stroke occurs when blood flow to an area of the brain is
disrupted thus causing oxygen deprivation to the cerebral tissue. The source of an
ischemic stroke can be a thrombus or an embolus. Thrombi, the most common cause of
ischemic stroke, occur in atherosclerotic blood vessels; plaque build-up and platelet
aggregation cause blood clots to form in arteries that circulate blood to the brain
(Kuriakose et al., 2020). Atherosclerotic plaques are most often found at arterial
bifurcations like those found in the internal carotid and vertebral arteries (Norris, 2019).
As previously mentioned, these arteries carry blood flow to the brain; when plaque
impedes oxygen rich blood flow to the brain, a thrombotic stroke ensues (Kuriakose et
al., 2020). Thrombotic strokes are most commonly seen in older adults with
atherosclerotic heart or peripheral arterial disease (Norris, 2019).
Embolic ischemic stroke occurs when a blood clot originates elsewhere and
travels to the brain. According to Gire & Wice (2017, p. 292), an embolus can also result
from fragments of atheromatous plaques, lipids, or air. The embolus embeds itself in a
smaller artery and obstructs blood flow to an area in the brain causing cell death.
According to Norris (2019), embolic strokes most often occur in the middle cerebral
artery from thrombi in the left side of the heart or from atherosclerotic plaque in the
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carotid arteries which dislodge and travel, eventually blocking the vessel. Embolic
strokes may be of cardiac origin, secondary to a myocardial infarction or atrial fibrillation
(Gire & Wice, 2017, p. 292). Other cardiac conditions such as rheumatic heart disease,
ventricular aneurysm, and bacterial endocarditis may also contribute to the formation of
emboli (Norris, 2019).
Ischemic strokes can occur without a known source of origin (cryptogenic).
According to Kamtchum-Tatuene et al. (2021), ischemic stroke is considered cryptogenic
when specific etiology is unknown; cryptogenic strokes represent approximately 30% of
all ischemic strokes. There are three subgroups of cryptogenic strokes: stroke with no
cause despite complete workup, stroke with various possible underlying causes, and
stroke with incomplete baseline workup. Stroke with no cause despite complete workup
is defined as an embolic stroke of unknown source (ESUS) (Kamtchum-Tatuene et al.,
2021). The etiology of ESUS is presumed embolic despite the absence of an identifiable
cardiac or arterial embolic source (Kamtchum-Tatuene et al., 2021). Embolic stroke of
unknown source refers specifically to non-lacunar stroke; it represents one of five types
of ischemic strokes (Kamtchum-Tatuene et al., 2021). Lacunar infarct is defined by
Micheli & Corea (2012), as small deep infarcts (less than 15 mm in diameter) in a single
penetrating artery.
Ischemic Stroke Patients Ineligible for Thrombolytics or EVT
Recommended interventions may not be appropriate for all AIS patients as
individuals may have a blocked cerebral vessel that is too distal to retrieve via
thrombectomy or the patient may be outside the EVT and/or treatment windows. Also,
patients may receive interventions without successful recanalization/perfusion. In these
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cases, hypertension will be allowed in the first 24 hours to allow as much perfusion to the
brain as possible. The patient will be monitored in the hospital and immediately placed
on antiplatelet therapy (Powers et al., 2019). To prevent future ischemic stroke, the
American Stroke Association [ASA], (n.d.) recommends aspirin 50-325 mg daily or
clopidogrel 75 mg daily; in some instances, dual therapy is recommended short term or
for specific patient cases.
Standard Treatment for Ischemic Stroke
Early recognition of stroke symptoms and advancement in treatment options have
contributed to stroke declining from the fourth leading cause of death in 2008 to the fifth
leading cause of death in 2013, according to Yang et al. (2017). In the United States,
stroke is still the fifth leading cause of death, behind heart disease, cancer, chronic lower
respiratory disease, and unintentional injuries/accidents. Worldwide, stroke is the second
leading cause of death after heart disease. Stroke continues to be a leading cause of
serious long-term disability, with an annual cost of approximately $33.9 billion (Yang et
al., 2017). Currently approved treatments for ischemic stroke include intravenous
thrombolytics, e.g., tPA, and/or performing endovascular procedures, e.g., EVT.
However, these interventions may not be indicated for all patients (Powers et al., 2019).
Thrombolytics
Tissue plasminogen activator (also known as alteplase) was approved for the
treatment acute ischemic stroke by the U.S. Food and Drug Administration (FDA) in
1996 (Tu, 2015). Tissue plasminogen activator, the gold standard and FDA approved
thrombolytic agent for acute stroke, is a protein that breaks down blood clots to restore
blood flow to a previously occluded area in the brain (Ischemic Stroke Treatment, 2018).
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According to the updated 2019 ASA guidelines, tPA should only be administered within
4.5 hours after the onset of stroke symptoms. Prior to administration, a computerized
tomography (CT) scan of the brain must be completed to rule out a hemorrhagic stroke
and blood pressures must be below 185/110 mm Hg prior to administration. Additionally,
there here must be no recent trauma or surgery and no intake of anticoagulant medication
in the last 24 hours. During the administration of tPA and the next 24 hours that ensue,
close monitoring of patients is pivotal because intracerebral hemorrhage (ICH) is a fatal
side effect of tPA.
Tenecteplase and reteplase are two thrombolytics still under research for the use
of acute ischemic stroke. Currently, these two thrombolytics are only indicated for the
management of acute myocardial infarction and have not been FDA approved for acute
ischemic stroke (Zitek et al., 2020). However, the updated 2019 ASA guidelines,
recognize that some institutions are moving towards the use of tenecteplase as first line
treatment of AIS in lieu of alteplase. According to Zitek et al. (2020) tenecteplase should
be the preferred treatment of AIS over alteplase as tenecteplase has greater fibrin
specificity, a longer half-life than alteplase, is less expensive, easier to administer, and
may cause less bleeding complications than alteplase. Despite these reasons, Zitek et al.
report the FDA has yet to approve tenecteplase for AIS in the United States although its
use is becoming more common.
Endovascular Thrombectomy (EVT)
Endovascular thrombectomy has become the gold standard for treating patients
with a large vessel occlusive stroke who are eligible according to criteria (Powers et al.,
2019). Large vessel occlusions (LVO) can occur in the anterior circulation which consists
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of the internal carotid (ICA), middle cerebral (MCA), and anterior cerebral (ACA)
arteries. They can also occur in the posterior circulation which includes the posterior
cerebral (PCA), vertebral, and basilar arteries. (Gire & Wice, 2017, p. 291). If diagnostic
imaging confirms the presence of an LVO, thrombectomy can be performed up to 24
hours after the onset of symptoms, per the updated 2019 ASA guidelines. Thrombectomy
is an endovascular procedure that involves the use of a wire-cage device called a stent
retriever; a catheter is threaded through the right femoral artery or the right radial artery
to retrieve the clot in the brain (Powers et al., 2019). Over the next 24 hours, it is vital to
monitor the groin or radial puncture site closely for hemorrhage and the presence of
pulses.
The updated 2019 ASA guidelines recommend treating eligible acute ischemic
stroke patients with large vessel occlusion with intravenous thrombolysis in addition to
endovascular thrombectomy. Mistry et al. (2017) emphasize the pros and cons to
receiving a dual therapy for ASI. For example, pre-treatment with intravenous
thrombolysis may extend the time it takes to receive thrombectomy, especially in smaller
hospitals that use the drip and ship method of care. The smaller hospitals may only be
able to administer tPA and then transfer patients to alternative locations to undergo EVT.
Alternatively, administration of intravenous thrombolytics such as tPA can lyse the clot
thus negating the need for thrombectomy; tPA is also beneficial for clots that are too
distal for successful endovascular retrieval. There is a risk of hemorrhagic
transformation, previously referred to as hemorrhagic conversion, with the administration
of intravenous thrombolytics. This risk was discussed by Mistry et al.; however, their
results showed equal odds of transformational hemorrhage in patients who received tPA
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with EVT and those who underwent EVT without prior administration of tPA. According
to the researchers, EVT attains a 70% to 80% success rate in patients with an LVO, while
intravenous thrombolysis without EVT has a 6% to 30% success rate in patients with an
LVO. A study by Karhi et al. (2018), supports the use of tPA and EVT together as their
combined use provides significantly greater outcome as compared to using tPA alone for
AIS patients with an LVO.
Stroke in Elderly Patients
The updated 2019 ASA guidelines for treating patients who have suffered an AIS
from an LVO do not exclude patients over the age of 75 from EVT procedures (Powers et
al., 2019). A research article by Malhotra et al. (2019) showed that EVT in elderly
patients (over 80 years old) revealed more favorable outcomes than tPA treatment alone.
Although Malhotra et al., discuss concerns raised about the use of EVT in elderly patients
related to poor functional outcomes, the ASA guidelines have no adult age restrictions for
EVT (Powers et al., 2019). Nonetheless, when considering treatment options, the
guidelines advise the careful consideration of preexisting conditions in addition to the
patient’s quality and quantity of life (Powers et al., 2019). Thus, the purpose of this
project was to determine if the use of endovascular thrombectomy (EVT) is
recommended for elderly patients over the age of 75 years of age who have suffered an
acute ischemic stroke from a large vessel.
Age-related complications.
The incidence of stroke increases with age and the risk doubles after the age of 55
(Kuriakose et al., 2020). Men under the age of 44 are hospitalized for AIS at a higher rate
than women in the same age group and one in five women between the ages of 55 and 75
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in the United States are at risk for a stroke (CDC, n.d.-b). Men have a higher incidence of
stroke but as women age, their stroke incidences rise as a result of their longer life
expectancy; women die more from strokes because they are living longer (Norris, 2019).
Women over the age of 75 with atrial fibrillation have a 20% increased risk of a stroke,
thus cardioembolic stroke occurs more often in women (Kuriakose et al., 2020). As
previously mentioned, ASA guidelines do not recommend an age cut off for EVT, but
patient comorbidities and baseline functional status should be taken into consideration
(Powers et al., 2019).
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Theoretical Framework
Evidence-based practice (EBP) allows healthcare professionals to rely on research
findings and science rather than tradition and belief. Evidence-based practice involves
recognizing a clinical issue, examining the literature, critically appraising the literature,
and establishing suitable interventions. Theoretical models of EBP guide advanced
practice professionals to endorse EBP, cultivate practice standards, protocols, and
interventions (McEwen et al., 2014).
The Iowa Model of Evidence-Based Practice to Promote Quality Care (see
Appendix A) was the theoretical framework used to guide this project. This model guides
nurses and advanced practice professionals when making clinical decisions that affect
patients (McEwen et al., 2014).
According to Titler et al. (2001), the first step in the Iowa Model is to recognize
either a problem-focused trigger or a knowledge-focused trigger where an EBP may need
to be incorporated for change to occur. The next step is for the nurse or team to decide
how much of a priority the problem is for the organization, department, or unit in which
they work. Once deemed a priority, a team is created to develop, evaluate, and implement
the EBP change. The team collects, analyzes, and critiques the research pertinent to the
problem requiring change. The team determines whether the studies are scientifically
sound and reliable enough to validate a practice change. The last step is to pilot the
practice change; if successful, the organization adopts this new practice.
When the Iowa Model is applied, it aids in the delivery of quality care to patients.
It is precise and has been utilized to address numerous clinical matters (McEwen et al.,
2014). The foundation of this project is evidence-based research thus the best evidence is
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comprehensively analyzed to provide quality care to patients. The Iowa model was
utilized in this project to determine if the use of endovascular thrombectomy is
recommended for elderly patients over the age of 75 years of age who have suffered an
acute ischemic stroke from a large vessel occlusion.
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Methods
Purpose
The purpose of this project was to determine if the use of endovascular
thrombectomy is recommended for elderly patients over the age of 75 years of age who
have suffered an acute ischemic stroke from a large vessel occlusion.
Inclusion/Exclusion Criteria
The inclusion criteria for this systematic review were randomized control trials
(RCT) articles including subjects over the age of 75, AIS from an LVO, received
thrombectomy, received tPA, and stroke occurring within 24 hours. The exclusion criteria
were articles including subjects under 18 years old, patients who received tenecteplase,
subjects with AIS but no LVO, studies that were not RCTs, and strokes occurring over 24
hours in the past.
Search Strategy
An extensive search in the Cumulative Index of Nursing and Allied Health
Literature (CINAHL) Plus with Full Text, PubMed, and Google Scholar database was
conducted to find articles published about EVT in elderly patients who suffered AIS from
an LVO. This search was limited to articles published between 2015 and 2020 using the
following search terms: stroke and thrombectomy in elderly patients, outcomes of
endovascular thrombectomy in elderly patients, endovascular treatment and elderly
patients, and benefits to thrombectomy for elderly patients.
The Preferred Reporting Items for Systematic reviews and Meta-Analyses
(PRISMA) framework was used in this project. PRISMA helps authors enhance the
reporting of systematic reviews and meta-analyses (Moher et al., 2009). Although
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randomized trials are the main focus of PRISMA, it can also be utilized in other types of
research, specifically the evaluation of interventions. PRISMA is composed of a 27-item
checklist (see Appendix B) that should be included when reporting a systematic review or
meta-analysis along with a four-phase flow diagram (see Appendix C) which includes the
different phases of a systematic review (Moher et al., 2009). The use of PRISMA is
helpful when critically appraising systematic reviews but the 27-item checklist is not
standard when assessing the quality of reviews.
Data Collection
Data was collected from each of the RCTs meeting criteria and recorded in tables
which include: the author, year, study purpose, method, number of subjects, outcomes,
results, and limitations (see Appendix D).
Critical Appraisal
The Critical Appraisal Skills Programme (CASP) was utilized to evaluate the
quality of research studies. The CASP tool facilitates the critical appraisal and
comprehension of research evidence, allowing the clinician to apply that evidence in
practice (Oxford Centre for Triple Value Healthcare Ltd (n.d.). The tool has seven
checklists (10-12 questions) divided into three sections to assess the validity of results
and its relevance to practice (see Appendix E).
Cross study analysis was conducted utilizing a comparison table including each
study type, adverse events, results, and limitations was created (see Appendix F).
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Results
Sixty studies were identified through the initial database search with no additional
studies identified through other sources. Five duplicate records were removed, and the
remaining studies were screened for eligibility. Forty-nine studies were excluded during
the screening process based on the inclusion and exclusion criteria of this systematic
review. Six studies met inclusion and were included in this systematic review.
Clinical characteristics of the studies include EVT, alteplase, use of the baseline
and postoperative National Institute of Health Stroke Scale (NIHSS), thrombolysis in
cerebral infarction scores (TICI), and modified Rankin Scale (mRS). The NIHSS is a 15item assessment tool used to measure stroke-related neurologic deficit (NIHSS, 2021).
The TICI scores are used to grade recanalization success after EVT. A score of 0/1 means
no/minimal reperfusion, 2a means partial filling of < 50% of the stroke territory, 2b
means partial filling ≥ 50% of the stroke territory, 2c means near complete perfusion
except for slow flow or few distal cortical emboli, and 3 is complete perfusion. Better
outcomes are seen with TICI scores of 2b/2c/3 (Tung et al., 2017). The mRS is used to
assess disability in patients with acute stroke; it ranges from 0, meaning no symptoms to
6, meaning death (Zeltzer, 2008).
Individual Studies
Alawieh et al. (2018) performed a multicenter retrospective chart review to
evaluate thrombectomy outcomes in acute ischemic stroke due to large vessel occlusion
for patients over and under the age of 80 (see Table D-1). Data was collected from seven
US-based comprehensive stroke centers from 2013 to 2017. Of the 1,442 patients
enrolled, 96 were excluded due to missing demographic information or procedural data.
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The inclusion criteria included: patients over 18 years old with anterior or posterior
circulation stroke, NIHSS score at presentation, and patients treated with stent retriever or
aspiration thrombectomy as first approach. The study proceeded with the remaining
1,346 patients; 52% were women. In addition to EVT, alteplase was administered to
45.5% of the patients. Patients were separated into two cohorts < 80 years old and those
aged ≥ 80 years old. There were 346 patients in the ≥ 80 group with an average age of 85
± 5 years compared with 62 ± 13 years in the younger group. Univariate analysis showed
a significantly higher percentage of women in the ≥ 80 age group (66% vs. 47%).
Patients ≥ 80 years old had a considerably higher number of comorbidities than the
younger cohort, i.e., hypertension and atrial fibrillation. On admission, the NIHSS score
was found to be higher in the ≥ 80 age group when compared with the younger cohort (17
± 7 vs.

16 ± 7). However, there were no significant differences found in prior stroke

history, rates of posterior circulation strokes, or in tPA administration between the two
groups.
The mRS at 90 days was used as the principal clinical outcome. The scores were
divided into good outcome (mRS 0-2) and poor outcome (mRS 3-6). Univariate and
multivariate analyses were performed to assess the independent effect of age greater than
80 years on outcome predictor. Subgroup analyses were also performed based on stroke
location, recanalization success, or thrombectomy technique used. Direct aspiration first
pass technique (ADAPT) was used in 58% of patients; the remaining patients underwent
stent retriever thrombectomy as first-line therapy. Post-procedural reperfusion with TICI
≥ 2b was seen in 89% of cases, a good outcome was seen in 37.5% of the cases at 90
days, and the total mortality at 90 days was 24.4%. The rate of postprocedural
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hemorrhage (PH) was 31%, and the rate of PH2-type hemorrhage (≥ 30% of infarcted
tissue occupied by hematoma) was 4.4%. The rate of functional independence (mRS 0-2)
after thrombectomy in elderly patients was considerably lower than in the younger
cohort. Age ≥ 80 was independently associated with increased mortality and poor
outcome at 90 days was significantly higher in the elderly population than in younger
adults (35% vs 20%, respectively). Age ≥ 80 independently predicted a higher rate of
postprocedural hemorrhage as compared to younger adults (42% vs 28%, respectively).
This study by Alawieh et al. suggests that age ≥ 80 is associated with increased mortality
and poor outcomes after EVT in multiple institutions. The study found age greater than
80 to be a predictor of poor outcomes (mRS 3–6).
A single center retrospective study by Karhi et al. (2018) was conducted at the
Kuopio University Hospital in Finland between 2009 and 2015 to determine if
thrombectomy in acute ischemic stroke is beneficial in octogenarians in comparison to
younger patients (see Table D-2). Initially, there were 261 patients chosen, but 62 were
excluded for not meeting inclusion criteria. The inclusion criteria were (a) age 18 years or
older, (b) large anterior occlusion (LAO) in the M1 or M2 segment of the middle cerebral
artery (MCA), or the internal carotid artery (ICA), (c) with or without an intracranial
thrombus component, (d) confirmed on the admission imaging, and (e) available followup information for 1 year after the AIS onset. The study continued with the final 199
patients, which included 76 females. There were 162 patients under 8o years old and 37
patients over 80 years old and over. There was a higher number of females in the elderly
group as compared to the younger group (78% vs. 29%, respectively). Alteplase was
administered to 57% of the patients.
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The study showed older patients as compared to younger patients had more
complications during hospitalization (41% vs. 24%, respectively), higher 3-month mRS
values (4.0 ± 2.3 vs. 2.8 ± 1.9, respectively), fewer favorable mRS values (mRS ≤ 2: 27%
vs. 52%, respectively), and higher 3-month (46% vs. 10%, respectively) and 1-year
mortality (49% vs. 11%, respectively). When comparing the mRS for pre-stroke and at 3
months post AIS, the older group had greater deterioration than the younger group.
Although the results of the study showed a worse recovery rate in patients over the age of
80 when compared to younger patients, 27% (n = 10) of the elderly patients benefited
from thrombectomy. Despite a small subject number in the elderly cohort, Karhi et al.
recommended EVT for patients over 80 years old after prudent consideration.
A single center retrospective study by Kim et al. (2017) was completed at a
Korean hospital between 2010 and 2015 (see Table D-3) which included 171 patients
who underwent thrombectomy following AIS. Among these patients, 113 of them were
over the age of 60 and were selected for the study. Patients < 60 years old with an LVO
were excluded from this study. The subjects were divided in to two subgroups: the very
elderly group aged 80 years and older (n = 20, 17.7%) and the aged group aged 60 to 79
years (n = 93, 82.3%)). There were fifty-five male patients (48.7%) in the study. In the
very elderly cohort, 80% (n = 16) were female and 20% (n = 4) male as compared to the
aged group with 45.2% (n = 42) female patients and 54.8% (n = 51) male. Most
occlusions were in the internal cerebral artery in both the very elderly group and the 6079-year-old groups (75% and 54.8%, respectively). Of the 113 patients, 44 in the 60-79
years old group and 3 in the >80 years old group received tPA as well as ETV.
Recanalization was unsuccessful in the very elderly cohort 40% (n = 8) of the time versus
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14% (n = 13) in the aged group and they were less likely to attain great reperfusion (TICI
score 2b and 3) than the aged group (75.2% vs. 40%, respectively).
The study showed no considerable differences in the rate of complications, i.e.,
hemorrhage, cerebral edema, or mortality, in either group. On the other hand, infarction
progression was witnessed nearly seven times more frequently in the very elderly group
with 3 out of 20 patients (15%) than the aged group with 2 out of 93 patients (2.2%).
Treatment outcome was assessed at discharge using the mRS. There were worse
outcomes in the very elderly group, with poor outcomes (mRS 5–6) in 65% of the very
elderly cohort versus 37.6% of the aged patients. The authors concluded these differences
were due to EVT being more difficult in the very elderly population due to an increased
infarction progression rate and distant occlusion sites.
A multicenter prospective study by Meyer et al. (2020) investigated the outcome
and safety of thrombectomy following ischemic stroke in nonagenarians in order to
improve decision making in this population (see Table D-4). Data was collected from 25
German institutions between 2013 and 2018. There were 203 patients ≥ 90 years old who
met the inclusion criteria for the study. Patients aged ≥ 90 enrolled in the German Stroke
Registry Endovascular Treatment (GSR-ET) were combined with a smaller cohort from
three additional tertiary stroke centers. (One hundred thirty-nine patients in the GSR
cohort and 64 patients who were not part of the GSR group). The inclusion criteria
included the diagnosis of AIS due to a large vessel occlusion within the anterior
circulation, thrombectomy, patient age ≥ 90 years, and a pre-stroke mRS 0 to 3. Patients
under 90 years old were excluded from the study. There were 203 patients with 77.8% (n
= 158) women included in the study. A total of 58.6% (n = 119) patients received tPA
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prior to thrombectomy. Thirteen patients declined to take part in the follow-up of the
study and outcome data was unavailable.
The rate of successful recanalization (TICI ≥ 2b) was 75.9% (n = 154). Patients
with successful recanalization (n = 143) had higher rates of good functional outcomes
(23.8%, n =34) versus patients with unsuccessful recanalization (14.9%, n =7)]) and
lower mortality at 90-days. Of the 193 patients contacted for follow-up, good functional
outcome (mRS ≤ 3) was observed in 21.6% (n = 41) at 90-days. In-hospital mortality for
the 203-patient sample was 27.1% (n = 55) which increased significantly for the followup group (n = 193) at 90 days to 48.9% (n = 93). Symptomatic intracranial hemorrhage
occurred in 3% (n = 6) of the total sample of patients. The study showed no differences in
outcome between patients treated before registry enrollment and those enrolled in the
GSR-ET.
Slawski et al. (2018) completed a multicenter prospective study to evaluate the
safety and efficacy of EVT following ischemic stroke in patients 80 years old and over
with baseline mRS of 0–4 (see Table D-5). Data was collected from 2015 to 2017 in two
Ohio tertiary care centers. Ninety-six patients ≥ 80 years old who received thrombectomy
after anterior circulation AIS were included in this study. To meet the inclusion criteria,
patients had to be over 80 years old, present with baseline mRS of 0–4 (mild-moderate),
and their Alberta Stroke Program Early CT Score (ASPECTS) on non-contrast CT had to
be > 6. The patients with severe disability (mRS 5), advanced dementia, and comfort care
measures in place were excluded. The 96 patients chosen to be in the study were divided
into two groups according to their baseline mRS: 0–1 indicating mild disability (n = 50)
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and mRS 2–4 indicating moderate disability (n = 46). The study included more 62.5 %
women (n = 60) and a total of 45.8% (n = 44) patients received tPA prior to EVT.
Good outcome (mRS ≤ 2) at 90 days was achieved in 33.7% (n = 32) of the
patients with 42.9% (n = 21) in the mild disability group and 23.9% (n = 11) in the
moderate disability cohort. The adverse effect of hemorrhagic complication was 37.5% (n
= 36), with 6.3% (n = 6) of those patients experiencing symptomatic ICH. The mortality
rate was 38.5% (n=37). The rates were considerably higher in the moderate disability
cohort in comparison to those in the mild disability group (52.2% vs. 26%, respectively).
In this study, one-third of the patients benefited from EVT; however, the best outcomes
were seen in the mild disability group who received EVT. Slawski et al. concluded that
EVT was a reasonable treatment of AIS in elderly patients.
A multicenter retrospective study was conducted by To et al. (2015) to examine
the benefit of thrombectomy following an acute ischemic stroke (Table D-6). Data from
patients over the age of 80 in a Michigan institution (Providence Hospital) was collected
from 2011 to 2014. There were 2,792 code strokes activated in their health system. Of the
171 patients of all ages who were given tPA, 98 patients underwent thrombectomy. There
were 223 patients over 80 years old but only 18 patients met the inclusion criteria for the
study; three of these patients received tPA. Fourteen (78%) of the patients were women.
The inclusion criteria were age over 80 years, had to have an LVO, and had to received
thrombectomy.
Of the 16.6% (n = 3) of patients who received tPA prior to EVT, 66.7% (n = 2)
had symptomatic ICH. There was no ICH found in patients who did not receive tPA. Of
the 18 patients in the study, 44.4% (n = 8) died. Adverse outcomes were seen in both tPA
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and thrombectomy patients. Variables were tested for good or poor outcome association.
Female gender was the only variable associated with poor outcome (85.7%, n = 12). A
favorable outcome (mRS ≤ 2) was achieved in 27.7%, (n = 5) out of the patients. The
authors concluded consideration of the 27.7% good outcome should positively influence
the decision to provide EVT to elderly patients. To et al. support EVT in patients over 80
years old because the alternative of not providing thrombectomy could result in an
overall detrimental aftermath.
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Summary and Conclusions
Stroke is a leading cause of disability and death worldwide. Stroke increases
disability in more than half of stroke survivors over the age of 65. Stroke occurs every 40
seconds in the United States and a stroke-related death occurs every three and a half
minutes. Although a stroke can occur at any age, the risks increase significantly with
advanced age and with risk factors like hypertension, diabetes, atrial fibrillation, smoking
and obesity (CDC, n.d.-a). Approved treatments for ischemic stroke currently include
intravenous thrombolytics (i.e., tPA) and/or endovascular thrombectomy. It is important
to consider the advantages and disadvantages of both treatments in every patient and even
more importantly in the elderly population.
This systematic review was conducted to determine if the use of endovascular
thrombectomy is recommended for elderly patients over the age of 75 years of age who
have suffered an acute ischemic stroke from a large vessel occlusion. The authors of four
of the six articles in this systematic review concluded that thrombectomy is safe and
effective in patients over the age of 75 years of age who have suffered an acute ischemic
stroke from a large vessel occlusion. Despite high mortality rates and less favorable
outcomes in the elderly cohorts in their study, the four authors unanimously concluded
that the alternative of not providing thrombectomy could have detrimental outcomes.
However, the authors of the four articles recommended prudence when considering
whether to perform EVT in elderly patients with an acute ischemic stroke from a large
vessel occlusion. Thus, every patient and circumstance are different.
Two of the six articles did not specifically state whether or not thrombectomy was
effective in elderly patients. Kim et al. (2017) highlighted the difficulties of performing
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EVT in elderly patients as a result of an increased infarction progression rate and distant
occlusion sites. On the other hand, their study showed no substantial differences in the
rate of complications (i.e., hemorrhage, cerebral edema, mortality) in either group.
Alawieh et al. (2018) found that age ≥ 80 was associated with increased mortality and
poor outcomes after thrombectomy in multiple institutions. This study raised concerns in
terms of risk-benefit and cost of performing EVT in elderly patients. Due to the
healthcare system’s emphasis on cost-effective care, Alawieh et al. (2018) believe there
needs to be great improvement in the selection criteria for elderly patients being
considered for thrombectomy.
The most significant limitation noted in the six articles was the lack of large
elderly cohorts. Due to small sample sizes of the elderly groups, mortality and less
favorable outcomes were amplified in comparison to the younger cohorts. In summary,
the majority of the articles from this systematic review recommended the use of
endovascular thrombectomy for elderly patients over the age of 75 years of age who have
suffered an acute ischemic stroke from a large vessel occlusion.
The overall findings of the systematic review suggest the use of endovascular
thrombectomy to be effective for elderly patients over the age of 75 years of age who
have suffered an acute ischemic stroke from a large vessel occlusion when patient
characteristics and comorbities are taken into consideration during treatment decision
making.
The limitations of this systematic review were the lack of large elderly cohorts
throughout the six studies, the authors’ definitions and measurements of good outcomes
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were not consistent, and two of the six studies had no conclusion as to whether EVT was
effective in elderly patients.
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Recommendations and Implications for Advanced Nursing Practice
According to Slawski et al. (2018), by 2050, strokes will more than double, with
the greatest percentage of affected patients being over the age of 75. Elderly patients have
been known to be excluded from clinical trials solely due to their age and comorbidities
(Karhi et al., 2018). Thus, there is limited evidence-based research to assist providers
make prudent decisions in regard to performing thrombectomy on elderly patients.
Advanced practice nurses (APRN) and other providers have an obligation to
provide care that is safe. Thrombectomy for elderly patients is still a controversial topic
in healthcare, thus it is the provider’s responsibility to assist patients and families come to
the best decision. The articles in this systematic review recommend lifesaving treatments
like thrombectomy for elderly patients over the age of 75 who have suffered an acute
ischemic stroke from a large vessel occlusion; however, this does not negate the careful
considerations which need to be discussed (i.e., preexisting conditions and baseline
functionality) for each patient, as every situation is different. Ultimately, the goal is to
preserve as much quality of life as possible for these stroke survivors.
APRNs can advocate for and educate their patients and families about the benefits
of receiving thrombectomy after suffering an acute ischemic stroke from a large vessel
occlusion. In addition, APRNs should educate their colleagues about the evidence
regarding thrombectomy in elderly patients and participate in further research about
thrombectomy in patients over the age of 75; this is of paramount importance. Strokes
will more than double by 2050, with the greatest percentage of affected patients being
over the age of 75 (Slawski et al., 2018). APRNs can help bridge the gap in the lack of
knowledge regarding EVT in the elderly population.
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Appendix D
Data Analysis Tables
Table D-1
Alawieh, A., Starke, R. M., Chatterjee, A., Turk, A., De Leacy, R., Rai, A. T., Fargen, K., Kan, P., Singh, J., Vilella, L., Nascimento, F. A., Dumont, T. M.,
McCarthy, D., & Spiotta, A. M. (2018). Outcomes of endovascular thrombectomy in the elderly: A ‘real-world’ multicenter study. Journal of NeuroInterventional
Surgery, 11(6), 545–553.
Purpose
To evaluate
thrombectomy
outcomes in
acute ischemic
stroke due to
large vessel
occlusion for
patients over
and under the
age of 80.

Design
Multicenter
retrospective
chart review.

Site/Sample

Methods

Outcomes
Measured

Results

• Data was collected from
seven US-based
comprehensive stroke
centers between January
2013 and December
2017.
• Inclusion: over 18 years
old’ anterior or posterior
circulation stroke,
NIHSS recorded at
presentation, treated with
stent retriever or
aspiration thrombectomy
as first approach.
• Total of 1,442 patients
were enrolled. Of these
patients, 96 were
excluded due to missing
demographic information
or procedural data. The
study proceeded with the
remaining 1,346 patients.
• Of the 1,346 patients,
346 were over 80 years
old.
• Of the 1346 patients,
52% were women.

• Patients over the age of 18
years with anterior or
posterior circulation ischemic
stroke were included.
• Patients were separated in to
over 80 years old group and
under 80 years old group.
• Univariate and multivariate
analysis were performed to
assess the independent effect
of age greater than 80 years
on outcome predictor.
• Subgroup analyses were also
performed based on stroke
location, recanalization
success, or thrombectomy
technique used.
• The average age in elderly
group was 85±5 years
compared with 62±13 years in
the younger population.
• Univariate analysis was used.
• There was a higher percentage
of women in the elderly group
which proved significant.
• Treatment with IV tPA was
provided to 45.5% of the
patients.

• The
modified
Rankin
Scale
(mRS) at
90 days
was used as
the primary
clinical
outcome.
• mRS scores
were
divided into
good
outcome
(0-2) and
poor
outcome
(3-6).

• Rate of functional independence (mRS 0-2) after
thrombectomy was considerably lower in elderly
patients.
• A direct aspiration first pass technique (ADAPT)
was used in 58% of patients and 42% underwent
stent retriever thrombectomy as first-line therapy.
• 89% had post-procedural reperfusion with TICI
≥2b
• A good outcome (mRS 0–2) was observed in
37.5% of cases at 90 days.
• 90-day overall mortality was 24.4%.
• Overall rate of postprocedural hemorrhage was
31%; rate of PH2-type hemorrhage was 4.4%.
• No differences were found between tPA and nontPA groups.
• Age ≥80 was independently associated with
increased mortality
and poor outcome.
• 90-day mortality was significantly higher in the
elderly group (35%) versus younger group (20%).
• Age ≥80 associated with negative outcome despite
thrombectomy technique, stroke location, or
success of recanalization.
• Age ≥80 independently predicted higher rate of
postprocedural hemorrhage (42%) versus age < 80
(28%), but not success of recanalization.
• Baseline deficit and number of clot retrieval
attempts, were associated with a lower likelihood
of good outcome.

Limitations
• The study was
retrospective.

•

Small sample size and
comparison of elderly
patients with trial
patients.
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Table D-2
Karhi, S., Nerg, O., Miettinen, T., Mäkipaakkanen, E., Taina, M., Manninen, H., Vanninen, R., & Jäkälä, P. (2018). Mechanical thrombectomy of large artery
occlusion is beneficial in octogenarians. In Vivo, 32(5), 1223–1230.
Purpose

Design

Site/Sample

Methods

Outcomes Measured

Results

Limitations

To determine if
thrombectomy
in acute
ischemic stroke
is beneficial in
octogenarians in
comparison to
younger
patients.

Single center
retrospective
study.

• The study took place
in Kuopio University
Hospital in Finland
between 2009 and
2015.
• Inclusion: age 18
years or older; LAO
in MCA (M1 or M2
segment) or ICA with
or without an
intracranial thrombus
component,
confirmed on the
admission imaging,
available follow-up
information for one
year after onset.
• Initially, 261 patients
prior to exclusions
• Of the 261 patients,
199 patients were
chosen.
• 38.2% (n = 76) were
female.
• Group 1: under 80
years old (n = 162).
• Group 2: 80 years old
and over (n = 37).

• Sixty-two patients were excluded: age
under 18 years, posterior circulation
occlusion, follow-up data not accessible,
secondary stroke occurring as a
complication of neurosurgical treatment,
and recurrent stroke during the study.
• The latter group included three patients
over 90 years old (91, 92, and 95 years); no
upper limit for patient age was set.
• There was a higher proportion of females
(78%) than males (29%) among the
octogenarians.
• Among all patients, the mean age differed
significantly between genders.
o Females: 72.9 ± 13.9 years.
o Males: 63.4 ± 10.8 years.
• Treatment with IV tPA was provided to
57% of the patients vs. 67%.
• A single observer, blinded to the
retrospective clinical information,
evaluated CTA images with the collateral
score system:
o CS=0: absent collaterals in > 50% of
affected M2 vascular region.
o CS=1: diminished collaterals in > 50%
of M2 region.
o CS=2: diminished collaterals in < 50%
of M2 region.
o CS=3: collateral abundance equal to
that on the contralateral side.
o CS=4: collateral abundance greater
than that on the contralateral side.

• The modified Rankin scale
(mRS) was used to
measure the degree of
disability.
• Baseline, imaging, and
procedural characteristics,
the 3-month modified
Rankin Scale (mRS), and
1-year mortality were
assessed.
• Postprocedural reperfusion
was considered successful
when a TICI score of 2b or
3 was achieved.

• Successful reperfusion
(TICI 2b or 3) was
achieved in 75.7% of the
older group and 74.7% of
the younger group.
• Older group had more
complications during
hospitalization (41%)
versus younger group
(24%), higher 3-month
mRS values (4.0 ± 2.3 vs.
2.8 ± 1.9, respectively),
fewer favorable mRS
values of ≤2 (27% vs.
52%, respectively),
higher 3-month (46% vs.
10%, respectively), and
1-year mortality (49% vs.
11%, respectively).
• Based on a comparison of
the mRS measured prestroke and at 3 months
after the AIS, the older
group demonstrated
greater deterioration than
the younger group.
• Older group was
considerably higher after
3 months.
• 27% (n = 10) of the older
patients achieved a
favorable result.

• Study was
retrospectively
conducted at
one hospital.
• Sixty-two
patients of the
261 that
underwent
EVT were
excluded due
to age <18
years old,
location of
stroke, lack of
follow-up data,
secondary
stroke
complications,
and recurrent
stroke during
study.
• There were
only 37
octogenarians
in comparison
to 162 younger
patients.
• There was a
higher
proportion of
females (78%)
than males
(29%) among
the 80 and over
cohort.
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Table D-3
Kim, D. H., Kim, S. U., Sung, J. H., Lee, D. H., Yi, H. J., & Lee, S. W. (2017). Significances and Outcomes of Mechanical Thrombectomy for Acute
Infarction in Very Elderly Patients: A Single Center Experience. Journal of Korean Neurosurgical Society, 60(6), 654–660.
https://doi.org/10.3340/jkns.2016.1212.004.
Purpose

Design

Site/Sample

To compare the
functional
outcomes and
complication
rates in very
elderly patients
(age ≥ 80 years)
and patients (60–
79 years) who
underwent
thrombectomy
following
ischemic stroke.

Single center
retrospective
study.

• One hospital in Korea had
171 patients underwent
thrombectomy between
January 2010 and June
2015.
• 113 were over age 60 and
met inclusion.
• Exclusion: patients < 60
years old.
• 17.7% were in the very
elderly group, aged ≥80
years (n = 20).
• 82.3% were in the aged
group, aged 60–79 years (n
= 93).
• 48.7% (n = 55) were male.
• 20% (n = 4) of the very
elderly patients, were male
compared to (54.8%) in the
aged group.
• Occlusions were mostly in
the internal cerebral artery
o 54.8% in the very elderly
group.
o 75% in the aged group.
• 41.5 % (n = 47) received
tPA.
o 15% (n = 3) in the very
elderly group.
o 47.3 % (n = 44) in the
aged group.

Methods
• Recanalization rates,
complications, death, and
disability were compared.
• Univariate logistic
regression models were
used to evaluate
recanalization and clinical
outcomes/complications.
• 41.5% (n = 47) received
tPA.
o 15 % (n = 3) in the very
elderly group.
o 47.3 % (n = 44) in the
aged group.

Outcomes
Measured

Results

Limitations

• Reperfusion was
classified by TICI
scores.
• Functional outcomes
at discharge were
measured according
mRS.

• The NIHSS scores upon
presenting to the ER did not
differ significantly between
the 60–79-year-old group
(13.9 ± 6.4) and the ≥80 group
(15.6 ± 6.7).
• 40% (n = 8) of the very
elderly cohort versus 14% (n
= 13) of the aged cohort and
less likely to achieve major
reperfusion (TICI 2b or 3)
than the younger group
(75.2% vs. 40%).
• There were no considerable
differences in the rate of
complications, i.e.,
hemorrhage, cerebral edema,
mortality, or re-operation in
the post-treatment period.
• Infarction progression was
witnessed seven times more
often in the very elderly group
(15%, n = 3) than the aged
group 2.2% n =2)
• 65% (n = 13) of the very
elderly group had poor
outcomes (mRS 5–6) versus
37.6% (n = 35) in aged group.

• Retrospective study
conducted in one
institution.
• Treatment methods
and procedures for
patients varied;
different
thrombectomy devices
and agents were used.
Early in the study,
wire-based maceration
was mainly used.
Later in the study,
stent retrievers and
balloon guiding
catheters were used.
• The follow-up period
ranged from two days
to several weeks,
which could be too
short to accurately
assess the results.
• The Korean Ministry
of Food and Drug
safety suggested tPA
use in patients ≥ 80
years old is
contraindicated. This
resulted in fewer cases
of IV tPA given to the
very elderly group.
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Table D-4
Meyer, L., Alexandrou, M., Flottmann, F., Deb-Chatterji, M., Abdullayev, N., Maus, V., Politi, M., Bernkopf, K., Roth, C., Kastrup, A., Hanning, U.,
Brekenfeld, C., Thomalla, G., Gerloff, C., Mpotsaris, A., Papanagiotou, P., Fiehler, J., Leischner, H., Wunderlich, S.,...Limmroth, V. (2020). Endovascular
treatment of very elderly patients aged ≥90 with acute ischemic stroke. Journal of the American Heart Association, 9(5), 1–7.
Purpose
Design
Site/Sample
Methods
Outcomes
Results
Limitations
Measured
This study
investigates
outcome and
safety of
thrombectomy
following
ischemic stroke
in
nonagenarians
in order to
improve
decision
making.

Multicenter
prospective
study.

• In 25 German institutions,
203 patients ≥ 90 years old
met the inclusion criteria
for the study between 2013
and 2018.
• Initially, there were 139
patients in 23 hospitals
enrolled; 64 patients were
added from three high
volume stroke centers.
• Inclusion: diagnosis of an
AIS attributed to a LVO
within the anterior
circulation, thrombectomy,
patient age ≥ 90 years at
the date of treatment, and a
pre-stroke mRS 0 to 3.
• Exclusion: patients < 90
years old.
• 77.8% (n = 158) of patients
were women.

• Patients aged ≥ 90 enrolled in the
German Stroke Registry
Endovascular Treatment (GSR-ET)
[n = 139] were combined with a
smaller cohort from three additional
tertiary stroke centers (n = 64).
• 58.6% (n =119) received tPA prior
to thrombectomy. Baseline
characteristics were compared by
using Fisher’s exact test for
categorical variables, Mann–
Whitney U test, and the unpaired
Student t test for continuous
variables. The Mann–Whitney U
test and McNemar test were
performed for comparing outcome
follow-up data. Univariable
regression was followed by
multivariable regression analysis to
identify independent predictors for
good functional outcomes (mRS ≤
3) at 90- day follow-up.

•
•
•
•

Baseline
characteristics.
TICI score.
mRS for functional
outcomes.
Complications
(symptomatic
intracranial
hemorrhage, serious
adverse events).

• Thirteen patients declined to take
part in the follow-up of the study
and outcome data was
unavailable.
• The rate of successful
recanalization (TICI ≥ 2b) was
75.9% (n = 154).
• Patients with successful
recanalization had higher rates of
good functional outcomes
23.8%, (n = 34) versus patients
with unsuccessful recanalization
14.9% (n = 7) and lower
mortality at 90-days.
• Good functional outcome (mRS
≤ 3) was observed in 21.6% (n =
41) at 90-days.
• In-hospital mortality was 27.1%
(n = 55) which increased
significantly at 90 days to 48.9%
(n = 93) of patients not lost to
follow-up.
• Symptomatic intracranial
hemorrhage occurred in 3% (n =
6) of all patients.
• There were no differences in
outcome between patients treated
before registry enrollment and
those enrolled in the GSR-ET.

• The study is not
generalizable to
patients under
the age of 90
years.
• 6.4% (n = 13)
patients
declined to take
part in the
follow-up of the
study and
outcome data
was unavailable
retrospectively.
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Table D-5
Slawski, D., Salahuddin, H., Shawver, J., Kenmuir, C., Tietjen, G., Korsnack, A., Zaidi, S., & Jumaa, M. (2018). Mechanical thrombectomy in elderly stroke
patients with mild-to-moderate baseline disability. Interventional Neurology, 7(5), 246–255.
Purpose

Design

Site/Sample

Methods

To evaluate the
safety and
efficacy of
thrombectomy
following
ischemic stroke
in patients over
the age of 80
with baseline
modified
Rankin Scale
(mRS) scores of
0–4.

Multicenter
prospective
study.

• Ninety-six
patients ≥ 80 years
old who received
thrombectomy
after an anterior
circulation
ischemic stroke in
two Ohio tertiary
care centers.
• Inclusion: age ≥
80, presented with
baseline mRS of
0–4 (mildmoderate), taken
for thrombectomy.
• Exclusion: severe
disability (mRS5),
advanced
dementia, and
comfort care
measures in place.
• Alberta Stroke
Program Early CT
Score (ASPECTS)
was > 6.
• Group 1: baseline
mRS: 0–1 (n = 50)
and group 2
baseline mRS 2–4
(n = 46).
• 62.5% (n = 60)
were women.
• 45.8% (n = 44)
received tPA prior
to thrombectomy.

• ASPECTS baseline mRS were used in
determining inclusion criteria.
• Continuous variables were compared
using the Student t test with the Welch
test or the Mann-Whitney test, and
categorical data with the Fisher exact test
when it was appropriate.
• A multivariate logistic regression analysis
was completed to assess for clinically
significant predictors of favorable
outcome.

•
•
•
•
•
•

Outcomes Measured

Results

Limitations

Baseline characteristics.
Time to treatment.
Rate of revascularization.
Procedural complications.
Mortality.
90-day good outcome defined
as a mRS of 0-2.

• Recanalization success rate
was insignificant between
the mild disability group
(84.0%) and the moderate
disability group (84.8%).
• Overall hemorrhagic
complication rate was
37.5% with 6.3% of the
patients experiencing
symptomatic ICH.
• Good outcome at 90 days
was achieved in 33.7% (n =
32) of the patients.
o 42.9% (n = 21) in the
mild disability group.
o 23.9% (n = 11) in the
moderate disability
group.
• The overall mortality rate
was 38.5% (n = 37). The
rates were considerably
higher in the moderate
disability cohort (52.2%),
in comparison to those in
the mild disability group
26%.

• The study was
retrospective.
• There may have
been selection
bias for patients
who presented
with less severe
symptoms or
had advanced
dementia.
• Sample size
may have been
too small to
detect
substantial
differences
between the
groups.
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Table D-6
To, C., Rajamand, S., Mehra, R., Falatko, S., Badr, Y., Richards, B., Qahwash, O., & Fessler, R. D. (2015). Outcome of mechanical thrombectomy in the very
elderly for the treatment of acute ischemic stroke: The real-world experience. Acta Radiologica Open, 4(9), 205846011559942.
Purpose
To examine the
benefit of
thrombectomy
following ischemic
stroke based on
patient outcomes.

Design
Multicenter
retrospective
study.

Site/Sample
• Data from
patients over
the age of 80
in two
Michigan
institutions
(Providence
Hospital and
Medical
Center).
• Inclusion: age
over 80 years,
LVO, and
received
thrombectomy.
• 2,792 strokes
presented from
January 2011
to June 2014
of which 223
patients over
80 years old.
• 18 patients
met the
inclusion
criteria.
• 16.7% (n = 3)
received tPA.
• 77.8% (n = 14)
patients were
women.

Methods
• Data from strokes meeting inclusion
criteria in the Michigan health system
institutions from January 2011 to June
2014 were examined (inpatient vs.
outpatient strokes were not discussed).
• Variables were tested for good or poor
outcome association.
• All categorical data were analyzed with
a chi-square test. Two sample t-tests
were used to analyze continuous
variables with a normal distribution.

Outcomes Measured

Results

Limitations

• Physiologic imaging findings.
• Use of intravenous
thrombolytics.
• Baseline and postprocedural
NIHSS score.
• TICI score.
• Functional outcomes (mRS) at
discharge and at 90 days.
• Discharge destination.

• 66.6% (n = 13) patients
had TICI 3 recanalization.
• 16.6% (n = 3) patients
received tPA prior to
thrombectomy.
o 66.7% (n = 2) of those
patients had
symptomatic ICH.
• There were no ICHs found
in patients who did not
receive tPA.
• 44.4% (n = 8) patients in
the study died.
• Adverse outcomes were
seen in both tPA and
thrombectomy patients.
• 27.7% (n = 5) had a
favorable outcome (mRS
≤ 2).
• Female gender was the
only variable associated
with poor outcome
(85.7%, n = 12).

• The study was
retrospective.
• Sample size
may have been
too small to
detect
substantial
differences in
the results.
• 77.8% (n = 14)
patients were
women.
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Appendix E
Critical Appraisal Skills Programme (CASP) Tables
Table E-1
Alawieh, A., Starke, R. M., Chatterjee, A., Turk, A., De Leacy, R., Rai, A. T., Fargen, K., Kan,
P., Singh, J., Vilella, L., Nascimento, F. A., Dumont, T. M., McCarthy, D., & Spiotta, A. M.
(2018). Outcomes of endovascular thrombectomy in the elderly: A ‘real-world’ multicenter
study. Journal of NeuroInterventional Surgery, 11(6), 545–553.
A. Are the results of the trial valid?
1.

Yes

Did the trial address a clearly focused issue?

X

2. Was the assignment of patients to treatments
randomized?

X

3. Were all of the patients who entered the trial
properly accounted for at its conclusion?
4. Were patients, health workers, and study
personnel “blind” to treatment?

X

5.

X
X

How large was the treatment effect?

1346 stroke patients

8. How precise was the estimate of the treatment
effect?

(p<0.05)

C. Will the results help locally?

Yes

9.

X

Can the results be applied in your context?

10. Were all clinically important outcomes
considered?
11. Are the benefits worth the harms and costs?

No

X

Were the groups similar at the start of the trial?

6. Aside from the experimental intervention, were
the groups treated equally?
B. What are the results?
7.

Can’t tell

Can’t tell

No

X
X
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Table E-2
Karhi, S., Nerg, O., Miettinen, T., Mäkipaakkanen, E., Taina, M., Manninen, H., Vanninen,
R., & Jäkälä, P. (2018). Mechanical thrombectomy of large artery occlusion is beneficial in
octogenarians. In Vivo, 32(5), 1223–1230.
A. Are the results of the trial valid?

Yes

1.

Did the trial address a clearly focused issue?

X

2.

Was the assignment of patients to treatments
randomized?

X

3.

Were all of the patients who entered the trial
properly accounted for at its conclusion?
Were patients, health workers, and study
personnel “blind” to treatment?

X

4.
5.

Can’t tell

No

X

Were the groups similar at the start of the trial?

6.

Aside from the experimental intervention, were
the groups treated equally?
B. What are the results?
7.

How large was the treatment effect?

8.

How precise was the estimate of the treatment
effect?

X
X

199 stroke patients
(p<0.05)

C. Will the results help locally?

Yes

9.

X

Can the results be applied in your context?

10. Were all clinically important outcomes
considered?
11. Are the benefits worth the harms and costs?

Can’t tell

X
X

No
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Table E-3
Kim, D. H., Kim, S. U., Sung, J. H., Lee, D. H., Yi, H. J., & Lee, S. W. (2017). Significances
and Outcomes of Mechanical Thrombectomy for Acute Infarction in Very Elderly Patients: A
Single Center Experience. Journal of Korean Neurosurgical Society, 60(6), 654–660.
https://doi.org/10.3340/jkns.2016.1212.004.
A. Are the results of the trial valid?

Yes

1.

Did the trial address a clearly focused issue?

X

2.

Was the assignment of patients to treatments
randomized?

X

3.

Were all of the patients who entered the trial
properly accounted for at its conclusion?
Were patients, health workers, and study
personnel “blind” to treatment?

X

4.
5.

Can’t tell

No

X

Were the groups similar at the start of the trial?

6.

Aside from the experimental intervention, were
the groups treated equally?
B. What are the results?
7.

How large was the treatment effect?

8.

How precise was the estimate of the treatment
effect?

X
X

113 stroke patients
(p<0.05)

C. Will the results help locally?

Yes

9.

X

Can the results be applied in your context?

10. Were all clinically important outcomes
considered?

X

11. Are the benefits worth the harms and costs?

X

Can’t tell

No
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Table E-4
Meyer, L., Alexandrou, M., Flottmann, F., Deb-Chatterji, M., Abdullayev, N., Maus, V., Politi,
M., Bernkopf, K., Roth, C., Kastrup, A., Hanning, U., Brekenfeld, C., Thomalla, G., Gerloff,
C., Mpotsaris, A., Papanagiotou, P., Fiehler, J., Leischner, H., Wunderlich, S.,...Limmroth, V.
(2020). Endovascular treatment of very elderly patients aged ≥90 with acute ischemic stroke.
Journal of the American Heart Association, 9(5), 1–7.
A. Are the results of the trial valid?

Yes

1.

Did the trial address a clearly focused issue?

X

2.

Was the assignment of patients to treatments
randomized?

X

3.

Were all of the patients who entered the trial
properly accounted for at its conclusion?
Were patients, health workers, and study
personnel “blind” to treatment?

X

4.
5.

Can’t tell

No

X

Were the groups similar at the start of the trial?

6.

Aside from the experimental intervention, were
the groups treated equally?
B. What are the results?
7.

How large was the treatment effect?

8.

How precise was the estimate of the treatment
effect?

X
X

203 stroke patients
(p=0.05)

C. Will the results help locally?

Yes

9.

X

Can the results be applied in your context?

10. Were all clinically important outcomes
considered?

X

11.

X

Are the benefits worth the harms and costs?

Can’t tell

No
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Table E-5
Slawski, D., Salahuddin, H., Shawver, J., Kenmuir, C., Tietjen, G., Korsnack, A., Zaidi, S., &
Jumaa, M. (2018). Mechanical thrombectomy in elderly stroke patients with mild-to-moderate
baseline disability. Interventional Neurology, 7(5), 246–255.
A. Are the results of the trial valid?

Yes

1.

Did the trial address a clearly focused issue?

X

2.

Was the assignment of patients to treatments
randomized?

X

3.

Were all of the patients who entered the trial
properly accounted for at its conclusion?
Were patients, health workers, and study
personnel “blind” to treatment?

X

4.
5.

No

X

Were the groups similar at the start of the trial?

6.

Aside from the experimental intervention, were
the groups treated equally?
B. What are the results?
7.

Can’t tell

X
X

96 stroke patients

How large was the treatment effect?

8. How precise was the estimate of the treatment
effect?

(p<0.05)

C. Will the results help locally?

Yes

9.

X

Can the results be applied in your context?

10. Were all clinically important outcomes
considered?

X

11. Are the benefits worth the harms and costs?

X

Can’t tell

No
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Table E-6
To, C., Rajamand, S., Mehra, R., Falatko, S., Badr, Y., Richards, B., Qahwash, O., & Fessler, R.
D. (2015). Outcome of mechanical thrombectomy in the very elderly for the treatment of acute
ischemic stroke: The real-world experience. Acta Radiologica Open, 4(9), 205846011559942.
A. Are the results of the trial valid?

Yes

1.

Did the trial address a clearly focused issue?

X

2.

Was the assignment of patients to treatments
randomized?

X

3.

Were all of the patients who entered the trial
properly accounted for at its conclusion?
Were patients, health workers, and study
personnel “blind” to treatment?

X

4.
5.

Can’t tell

No

X

Were the groups similar at the start of the trial?

6.

Aside from the experimental intervention, were
the groups treated equally?
B. What are the results?
7.

How large was the treatment effect?

8.

How precise was the estimate of the treatment
effect?

X
X

18 stroke patients
(p≤0.05)

C. Will the results help locally?

Yes

9.

X

Can the results be applied in your context?

10. Were all clinically important outcomes
considered?
11. Are the benefits worth the harms and costs?

Can’t tell

X
X

No
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Appendix F
Cross Analysis Table
Author,
Year
Alawieh et
al.,
2018

Karhi et al.,
2018

Comparison

Adverse Events

Study Results

Limitations

• Multicenter retrospective chart review in
seven US-based comprehensive stroke
centers.
• 1346 patients.
o 346 were ≥80 years old.
o 52% were women.
• Patients ≥ 18 years old with anterior or
posterior circulation.
• Patients were separated into 80 and over
year old cohort and under 80-year-old
cohort.
• Patients were treated with stent retriever
or aspiration thrombectomy. IV tPA was
provided to 45.5% of patients.

• The rate of functional
independence after
thrombectomy in elderly
patients was considerably
lower than for the younger
cohort.
• Age ≥80 was
independently associated
with increased mortality
and poor outcome.
• Age ≥80 independently
predicted higher rate of
postprocedural
hemorrhage (42% vs
28%).

• Direct aspiration catheters first pass technique (ADAPT)
was used in 58% of patients; the remainder underwent
stent retriever thrombectomy as first-line therapy.
• Post- procedural reperfusion with TICI ≥ 2b was reported
in 89% of cases.
• A good outcome (mRS 0–2) was observed in 37.5% of the
cases at 90 days and the overall mortality at 90 days was
24.4%.
• The overall rate of postprocedural hemorrhage was 31%,
and the rate of PH2-type hemorrhage was 4.4%.
• No differences were found between the tPA and non-tPA
groups.

• The study was retrospective.
• Small sample size and
comparison of elderly patients.

• Single center retrospective study in
Kuopio University Hospital in Finland.
• Of the 199 patients included, 76 were
female.
• There were 162 patients ≤ 8o years old
and 37 patients ≥ 80 years old.
• Patients ≥18 years with a LAO in the
middle cerebral artery (MCA; M1 or M2
segment) or in the internal carotid artery
(ICA).
• Treatment with IV tPA was provided to
57% of the patients.

• Based on a comparison of
the mRS measured prestroke and at 3 months
after the AIS, the older
group demonstrated
greater deterioration than
the younger group.
• Mortality was considerably
higher in the older group
than in the younger group
after 3 months.
• Ten out of the 37 older
patients achieved a
favorable result.

• Successful reperfusion (TICI 2b or 3) was achieved in
75.7% of the older group and 74.7% of the younger group.
• Older patients had more complications than younger
group during hospitalization (41% vs. 24%, respectively),
higher 3-month mRS values (4.0 ± 2.3 vs. 2.8 ± 1.9,
respectively), fewer favorable mRS values (mRS ≤ 2:
27% vs. 52%, respectively), and higher 3-month (46% vs.
10%, respectively) and 1-year mortality (49% vs. 11%,
respectively).

• The study was retrospectively
conducted at one hospital.
• There were only 37 octogenarians
in comparison to 162 younger
patients.
• Sixty-two patients of the 261 that
underwent EVT were excluded
due to age <18 years old, location
of stroke, lack of follow-up data,
secondary stroke complications,
and recurrent stroke during study.
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Author,
Year

Comparison

Adverse Events

Study Results

Limitations

Kim et al.,
2017

• Single center retrospective study in Korea
included 113 patients aged 60 and over.
• Treatment outcomes were assessed at
discharge using the mRS.
• The study compared the functional
outcomes and complication rates in very
elderly patients (age ≥ 80 years) and aged
patients (60-79 years) who underwent
thrombectomy following ischemic stroke.
• Most occlusions were in the internal
cerebral artery in both the very elderly
and aged subgroups (54.8% and 75%,
respectively).
• Of the 113 patients, 47 received tPA.
o 3 in the very elderly group.
o 44 in the aged group.

• There were no
considerable differences in
the rate of complications,
i.e., hemorrhage, cerebral
edema, mortality, or reoperation in the posttreatment period.
• Conversely, infarction
progression was witnessed
almost seven times more
often in the very elderly
group with 15% (n = 3) of
patients than the aged
group with 2.25% (n = 2)
of patients.

• The very elderly cohort were approximately three times
more likely to have failed recanalization with 40% (n =
8) of patients versus 14% (n = 14) of the patients.
• The very elderly group was less likely to achieve major
reperfusion (TICI score 2b and 3) than the aged group
(75.2% vs. 40%, respectively).
• There were worse outcomes in the very elderly group,
with poor outcomes (mRS 5–6) in 65% of very elderly
patients versus 37.6% in aged patients.

• The study was retrospectively
conducted in one single institution.
• Treatment methods and procedures
for patients varied as different
thrombectomy devices and agents
were used.
o Early in the study, wire-based
maceration was mainly used.
o Later in the study, stent
retrievers and balloon guiding
catheters were used.
• The follow-up period ranged from
two days to several weeks, which
could be too short to accurately
assess the results.
• The Korean Ministry of Food and
Drug safety suggested tPA use in
patients ≥ 80 years old is
contraindicated which resulted in
fewer cases of IV tPA given to the
very elderly group.

Meyer et al.,
2020

• Multicenter prospective study in 25
German institutions.
• Included were 203 patients ≥90 years old.
• Initially, 139 patients in 23 hospitals were
enrolled and then 64 patients were added
from three high volume stroke centers.
• Inclusion criteria included the diagnosis
of an acute ischemic stroke attributed to a
large vessel occlusion within the anterior
circulation, thrombectomy.
• 77.8% (n = 158) were women.
• 58.6% (n = 119) of patients received tPA
prior to thrombectomy.

• In-hospital mortality for
the entire sample was
27.1% (n = 55).
• Mortality at 90 days for
the sample excluding those
lost to follow-up was
48.9% (n = 93).
• Symptomatic intracranial
hemorrhage occurred in
3% (n = 6) of patients.

• Thirteen patients declined to take part in the follow-up
of the study and outcome data was unavailable.
• The rate of successful recanalization (TICI ≥ 2b) was
75.9% (n = 154).
• Patients with successful recanalization had higher rates
of good functional outcomes (23.8%, n = 34) versus
those with unsuccessful recanalization (14.9%, n = 7))
and lower mortality at 90-days.
• Good functional outcome (mRS ≤ 3) was observed in
21.6% (n = 41) of patients reached for follow-up at 90days.
• In-hospital mortality for the entire sample was 27.1% (n
= 55).
• Mortality at 90 days for the sample excluding those lost
to follow-up was 48.9% (n = 93).
• Symptomatic intracranial hemorrhage occurred in 3% (n
= 6) of patients.
• There were no differences in outcomes between patients
treated before registry enrollment and those enrolled in
the GSR-ET.

• Study was prospectively conducted.
• The study lacked good
generalizability due to the exclusion
of patients under the age of 90 years
old.
• Thirteen patients declined to take
part in the follow-up of the study
and outcome data was unavailable
retrospectively. Thus, they were
excluded from the final functional
outcome analysis.
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Author,
Year

Comparison

Adverse Events

Study Results

Limitations

Slawski et al.,
2018

• Multicenter prospective study in two Ohio
tertiary care centers.
• Study included 96 patients ≥ 80 years old
who received thrombectomy after an
anterior circulation ischemic stroke.
• Patients ≥ 80 who presented with baseline
mRS of 0–4 (mild-moderate) were
included and taken for thrombectomy.
Patients with severe disability (mRS 5),
advanced dementia, and comfort care
measures in place were excluded.
• Patients were divided into two groups
according to their baseline mRS: 0–1
indicating mild disability (n = 50) and 2–4
indicating moderate disability (n = 46).
• The study included more women than
men 62.5% (n = 60).
• A total of 45.8% (n = 44) patients
received tPA before thrombectomy.

• Hemorrhagic
transformation rate was
37.5% (n = 36) with 6.3%
(n = 6) of the patients
experiencing symptomatic
ICH.
• The overall mortality rate
was 38.5% (n = 37). Rates
were considerably higher
in the moderate disability
cohort (52.2%) in
comparison to those in the
mild disability group
(26%).

• Differences in recanalization success rate was
insignificant between mild disability group and
moderate disability group (84.0 % vs. 84.8%,
respectively).
• Hemorrhagic complication rate was 37.5%, with 6.3%
of the patients experiencing symptomatic ICH.
• Good outcome (mRS 0-2) at 90 days was achieved in
33.7% of the patients.
o 43% in the mild disability group.
o 23.9% in the moderate disability cohort.
• The overall mortality rate was 38.5%. The rates were
considerably higher in the moderate disability cohort, in
comparison to those in the mild disability group (52.2%
vs. 26% respectively).

• The study was retrospective.
• There may have been bias selection
for patients who presented with less
severe symptoms or had advanced
dementia.
• Sample size may have been too
small to detect substantial
differences between the groups.

To et al.,
2015

• Multicenter retrospective study in a
Michigan institution (Providence
Hospital) that included patients over the
age of 80.
• There were 2,792 code strokes activated.
• 223 patients over 80 years old. Only 18
patients over 80 years old met the
inclusion criteria for the study (age over
80 years, had to have an LVO, had to
received thrombectomy).
• 16.6% (n = 3) of those 18 patients
received tPA.
• 77.8% (n = 14) of those 18 patients were
women.

• 16.6% (n = 3) patients
received tPA prior to
thrombectomy
o 66.7% (n = 2) had
symptomatic ICH.
• 44.4% (n = 8) of the 18
patients in the study died.
• Adverse outcomes were
seen in both tPA and
thrombectomy patients.
Female gender was the
only variable associated
with poor outcome (12 out
of the 14 women).

• 66.6% (n = 13) patients had TICI 3 recanalization.
• 16.6% (n = 3) patients received tPA prior to
thrombectomy.
o 66.7% (n =2) had symptomatic ICH.
• There were no ICHs found in patients who did not
receive tPA.
• 44.4% (n = 8) of the 18 patients in the study died.
• Adverse outcomes were seen in both tPA and
thrombectomy patients.
• A favorable outcome (mRS ≤ 2) was achieved in 27.7%
(n = 5) patients.
• Variables were tested for good (mRS ≤ 2) or poor
outcome (mRS ≥ 2) association.
o Female gender was the only variable associated with
poor outcome (92%, n = 12).

• The study was retrospective.
• Sample size may have been too
small to detect substantial
differences in the results.
• 77.8% (n = 14) of the patients in the
study were women.

